Tower Research Capital (TRC)’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,697
| Closed | -$3.17K | – | 5673 |
|
|
2024
Q4 | $3.17K | Sell |
1,697
-3,852
| -69% | -$7.2K | ﹤0.01% | 4695 |
|
|
2024
Q3 | $4.31K | Sell |
5,549
-4,069
| -42% | -$3.16K | ﹤0.01% | 4592 |
|
|
2024
Q2 | $7.21K | Buy |
9,618
+2,340
| +32% | +$1.76K | ﹤0.01% | 4484 |
|
|
2024
Q1 | $7.72K | Buy |
7,278
+529
| +8% | +$561 | ﹤0.01% | 4158 |
|
|
2023
Q4 | $7.09K | Buy |
+6,749
| New | +$7.09K | ﹤0.01% | 4660 |
|
|
2023
Q2 | – | Sell |
-98
| Closed | – | – | 6274 |
|
|
2023
Q1 | $0 | Buy |
+98
| New | – | ﹤0.01% | 6192 |
|
|
2022
Q4 | – | Sell |
-8,290
| Closed | -$11K | – | 6275 |
|
|
2022
Q3 | $11K | Buy |
8,290
+3,947
| +91% | +$5.24K | ﹤0.01% | 4457 |
|
|
2022
Q2 | $9K | Buy |
4,343
+936
| +27% | +$1.94K | ﹤0.01% | 4578 |
|
|
2022
Q1 | $21K | Sell |
3,407
-2,872
| -46% | -$17.7K | ﹤0.01% | 3492 |
|
|
2021
Q4 | $79K | Buy |
6,279
+3,786
| +152% | +$47.6K | ﹤0.01% | 2394 |
|
|
2021
Q3 | $229K | Sell |
2,493
-1,825
| -42% | -$168K | 0.01% | 1690 |
|
|
2021
Q2 | $229K | Buy |
4,318
+1,446
| +50% | +$76.7K | 0.01% | 1817 |
|
|
2021
Q1 | $103K | Sell |
2,872
-2,088
| -42% | -$74.9K | ﹤0.01% | 2564 |
|
|
2020
Q4 | $138K | Sell |
4,960
-9,395
| -65% | -$261K | ﹤0.01% | 2052 |
|
|
2020
Q3 | $718K | Buy |
14,355
+11,919
| +489% | +$596K | 0.01% | 1297 |
|
|
2020
Q2 | $113K | Buy |
2,436
+2,100
| +625% | +$97.4K | ﹤0.01% | 2350 |
|
|
2020
Q1 | $15K | Buy |
+336
| New | +$15K | ﹤0.01% | 1843 |
|
|
2019
Q3 | – | Sell |
-373
| Closed | -$16K | – | 4443 |
|
|
2019
Q2 | $16K | Buy |
+373
| New | +$16K | ﹤0.01% | 2304 |
|